Preponderant impact of the chemosensitivity assessed by the modeled CA-125 kinetic parameter KELIM on the success of the first line treatment: Pooled analysis of AGO-OVAR 7, AGO-OVAR 9 and ICON7 trials--a GINECO-GINEGEPS study

Bibliographic Details
Title: Preponderant impact of the chemosensitivity assessed by the modeled CA-125 kinetic parameter KELIM on the success of the first line treatment: Pooled analysis of AGO-OVAR 7, AGO-OVAR 9 and ICON7 trials--a GINECO-GINEGEPS study
Authors: You, B., Tod, M., Leary, A., Ray-Coquard, I., Lortholary, A., Hardy-Bessard, A.C., Perren, T., Cook, A., Pfisterer, J., Bois, A.D., Kurzeder, C., Burges, A., Peron, J., Freyer, G., Colomban, O.
Source: In Gynecologic Oncology October 2020 159 Supplement 1:339-340
Database: ScienceDirect
More Details
ISSN:00908258
DOI:10.1016/j.ygyno.2020.05.627
Published in:Gynecologic Oncology
Language:English